Results 211 to 220 of about 20,954 (250)

Treatment of advanced pseudomyxoma peritonei using cytoreductive surgery including total gastrectomy and perioperative chemotherapy

Journal of Surgical Oncology, 2021
Pseudomyxoma peritonei is a disease caused by the widespread distribution of mucinous tumor into the peritoneal space from a perforated appendiceal neoplasm.
P. Sugarbaker, D. Chang
semanticscholar   +1 more source

Lymph node positive pseudomyxoma peritonei.

European Journal of Surgical Oncology, 2022
BACKGROUND Appendiceal mucinous neoplasms are routinely accompanied by peritoneal metastases at the time of diagnosis of the primary appendiceal tumor. In contrast, liver metastases and lymph node metastases are unusual.
P. Sugarbaker, D. Chang
semanticscholar   +1 more source

Pseudomyxoma peritonei

Der Onkologe, 2015
Hintergrund Mit einer Inzidenz von 1 bis 2 Erkrankungen pro 1.000.000 Einwohner pro Jahr stellt das Pseudomyxoma peritonei (PMP) eine extrem seltene Erkrankung dar. Haufigster Ursprungsort des PMP ist die muzinose Neoplasie der Appendix. Andere intra- und extraabdominale Organe kommen als Primarius weitaus seltener vor.
L. März, P. Piso
openaire   +1 more source

Pseudomyxoma peritonei peritonitis

BMJ Case Reports
Pseudomyxoma peritonei (PMP) is a rare neoplastic condition characterised by gelatinous ascites, which generally arise from mucin-producing appendiceal tumours. Presentation is variable but requires prompt recognition to ensure appropriate specialist management due to risk of malignancy.
Pranathi Yannamani, Lillian Chungu, Rajesh Shetty, Bankole Oyewole   +3 more
openaire   +2 more sources

Pseudomyxoma Peritonei

Current Problems in Surgery, 2008
Robert M, Smeenk, Sjoerd C, Bruin, Marie-Louise F, van Velthuysen, Victor J, Verwaal   +3 more
  +8 more sources

Pseudomyxoma Peritonei

Archives of Surgery, 1970
J, Parsons, G F, Gray, B, Thorbjarnarson
openaire   +2 more sources

Managing Recurrent Pseudomyxoma Peritonei in 430 Patients After Complete Cytoreduction and HIPEC: A Dilemma for Patients and Surgeons

Annals of Surgical Oncology, 2021
Nima Ahmadi, D. Kostadinov, S. Sakata, W. Ball, J. Gandhi, N. Carr, A. Tzivanakis, S. Dayal, F. Mohamed, T. Cecil, B. Moran   +10 more
semanticscholar   +1 more source

Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and Outcomes

Annals of Surgical Oncology, 2022
D. Baratti, S. Kusamura, M. Guaglio, M. Milione, F. Pietrantonio, T. Cavalleri, F. Morano, M. Deraco   +7 more
semanticscholar   +1 more source

Prevalence and incidence of pseudomyxoma peritonei in urban China: A nationwide retrospective cohort study.

European Journal of Surgical Oncology, 2022
Jingnan Feng, Ayuba Hu, Lu Xu, Lili Liu, Guozhen Liu, Jinxi Wang, Pei-Rong Gao, Cong-rong Liu, Shengfeng Wang, S. Zhan   +9 more
semanticscholar   +1 more source

PSEUDOMYXOMA PERITONEI

The Lancet, 1969
J M, Little, J P, Halliday, D C, Glenn
openaire   +4 more sources